David Fang

Finance Director & Assistant Company Secretary

Mr. Fang joined Immutep in March 2018. He was previously Group Finance Manager at Kazia Therapeutics Limited, which is an ASX and NASDAQ dual listed biotechnology company developing oncology drug.

After completion of his Master of Professional Accounting degree, Mr. Fang started his career as Auditor at PricewaterhouseCoopers (PwC) in China. He has over 12 years’ accounting and auditing experience across various industries including biotechnology, manufacturing and healthcare.

Mr. Fang has Master of Professional Accounting degree from Western Sydney University and Master of Commerce degree in Information System and Technology from Macquarie University. He is a member of CPA Australia.

Go back